771553-05-0

Basic information

• Product Name: Carbamic acid, [cis-4-[(3,4-difluorobenzoyl)amino]cyclohexyl]-, 1,1-dimethylethyl ester
• CAS NO: 771553-05-0
• Molecular Formula: C18H24F2N2O3
• Molecular Weight: 354.397
• Mol File: 771553-05-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [cis-4-[(3,4-difluorobenzoyl)amino]cyclohexyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [cis-4-[(3,4-difluorobenzoyl)amino]cyclohexyl]-, 1,1-dimethylethyl ester(771553-05-0)
• EPA Substance Registry System: Carbamic acid, [cis-4-[(3,4-difluorobenzoyl)amino]cyclohexyl]-, 1,1-dimethylethyl ester(771553-05-0)

Safety Data

• Hazardous Substances Data: 771553-05-0(Hazardous Substances Data)

Upstream product

• 247570-24-7 tert-butyl N-[(1s,4s)-4-aminocyclohexyl]carbamate 
• 76903-88-3 3,4-difluorobenzoyl chloride 
• 455-86-7 3,4-Difluorobenzoic acid 

Downstream Products

• 771545-82-5 N-(cis-4-amino-cyclohexyl)-3,4-difluoro-benzamide 

Relevant articles and documents

PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF

The present invention encompasses novel substituted pyrimidine compounds of Formula (I): which act as MCH receptor antagonists. These compounds are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson’s disease, epilepsy, and addiction.